Free Essay

Quality of Life of a Person with Parkinson's Disease

In:

Submitted By dbetcher
Words 1824
Pages 8
Rev. Latino-Am. Enfermagem
2012 Mar.-Apr.;20(2):384-91 www.eerp.usp.br/rlae

Original Article

Quality of life of a person with Parkinson’s disease and the relationship between the time of evolution and the severity of the disease

Fabiana Magalhães Navarro-Peternella1 Sonia Silva Marcon2

Parkinson’s disease can cause disability and decrease the quality of life in its sufferers. The aim of this study was to evaluate the quality of life of a group of people with Parkinson’s disease and whether a relationship exists between time of evolution and severity of the disease. Secondary analysis was carried out on transversal data collected from 40 individuals with Parkinson’s disease registered in the Parkinson’s Association of Maringá, in MaringáPR-Brazil. Measures: three instruments were applied: a socio-demographic questionnaire, the Hoenh and Yahr Scale and the Parkinson’s Disease Questionnaire (PDQ-39). According to PDQ-39, men referred to a lower quality of life, although, statistically, there was no significant difference between the two genders. Differences were only observed in the dimensions of “activities of daily living” and “social support”, in which men presented higher impairment, and “emotions” and “bodily discomfort”, where women showed higher impairment. Furthermore, severity of disease tended to lead to a perception of lower quality of life regarding the dimensions of “activities of daily living” and “cognition”, which is relevant to improve clinical guidance and intervention. Descriptors: Parkinson’s Disease; Chronic Disease; Quality of Life.

1 2

MSc, Unidade de Ensino Superior Ingá, Universidade de Maringá, Brazil. Free lecturer, Associate Professor, Centro de Ciências da Saúde, Universidade Estadual de Maringá, Brazil.

Corresponding Author: Fabiana Magalhães Navarro-Peternella Av. Colombo, 9727, km 130 Jardim Industrial CEP: 87070-810, Maringá, PR, Brasil E-mail: navarrofabiana@gmail.com

385 Qualidade de vida de indivíduos com Parkinson e sua relação com tempo de evolução e gravidade da doença
A doença de Parkinson pode ser incapacitante e prejudicar a qualidade de vida de seus portadores. O objetivo do estudo foi avaliar a qualidade de vida de indivíduos com Parkinson e identificar relações com o tempo de evolução e gravidade da doença. Os dados foram coletados na cidade de Maringá, PR, Brasil, com 40 indivíduos cadastrados na Associação Maringaense de Parkinson, por meio da aplicação de três instrumentos: questionário sociodemográfico, escala de Hoenh e Yahr e PDQ-39. De acordo com o PDQ-39, os homens referiram pior qualidade de vida, embora sem diferenças estatísticas entre os sexos. Diferenças foram observadas apenas na dimensão “atividades de vida diária” e “apoio social”, com os homens apresentando maior acometimento e “bem-estar emocional” e “desconforto corporal”, com maior comprometimento entre as mulheres. Por outro lado, a gravidade da doença apresentou tendência a pior percepção na qualidade de vida nas dimensões atividades de vida diária e cognição, pontos relevantes para melhor orientação clínica e intervenção. Descritores: Doença de Parkinson; Doença Crônica; Qualidade de Vida.

Calidad de vida de las personas con enfermedad de Parkinson y su relación con la evolución en el tiempo y la gravedad de la enfermedad
La enfermedad de Parkinson puede llegar a ser incapacitante y afectar a la calidad de vida de los pacientes. El objetivo de este estudio fue evaluar la calidad de vida de las personas con Parkinson e identificar las relaciones con el transcurso del tiempo y la gravedad de la enfermedad. Los datos fueron recogidos en la ciudad de Maringá-PRBrasil, con 40 personas indexadas en la “Associação Maringaense de Parkinson”, a través de la aplicación de tres instrumentos: cuestionario sociodemográfico, escala de Hoenh e Yahr y PDQ-39. De acuerdo con el PDQ-39, los hombres reportaron peor calidad de vida, aunque no hubo diferencias estadísticas entre los sexos. Las diferencias apenas se observaron en la dimensión “actividades de vida diaria” y “apoyo social”, con los hombres presentando una mayor participación y “bienestar emocional” e “incomodidad física” con una más grave entre las mujeres. Por otra parte, la gravedad de la enfermedad mostró una tendencia a empeorar la percepción en la calidad de vida en las dimensiones de las actividades de la vida diaria y cognición, puntos importantes para una mejor orientación e intervención clínica. Descriptores: Enfermedad de Parkinson; Enfermedad Cronica; Calidad de Vida.

Introduction
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease among the elderly, affecting 1 to 3% of this population
(1-2)

related to the quality of life(4). This takes place because the evolution of the disease causes an increase in limitations to perform activities of daily living (ADL)(1,5) combined with the appearance of cognitive dysfunction and bodily disorders, increasing the impact on the QoL, and including physical, psychological, emotional, social and economic aspects(2,6-7). Individuals with a chronic illness, such as Parkinson’s disease, must deal with physical discomfort as well as loss of social relationships, financial activities, work and leisure(8).

. In Brazil, a study
(3)

conducted in the state of Minas Gerais found that 3.3% of individuals over 65 years of age presented PD . Due to its progressive and chronic characteristics, the disease affects the quality of life (QoL) of patients. At the onset of the disease, the physical dimensions seem to be the most affected, since, initially, there are motor symptoms. However, as the disease progresses, there is a development of alterations involving other dimensions www.eerp.usp.br/rlae 386

Rev. Latino-Am. Enfermagem 2012 Mar.-Apr.;20(2):384-91. Health related quality of life in patients with Professionals, free speech therapy and physiotherapy is offered, along with other physical activities. Currently, the association has 50 PD patients enrolled, 40 of whom live in Maringá and the others in neighboring cities. The inclusion criteria defined for this study were: to be a PD patient, enrolled in PAM and living in Maringá. The exclusion criterion was: to present another neurodegenerative related disease (dementia, neuropathies, among others). None of the individuals living in Maringá presented neurodegenerative related complications cognitive that disease and, therefore, all 40 were included in the study. The study participants were evaluated individually, using three instruments: 1) a socio-demographic questionnaire, to collect data such as gender, age, ethnology, marital status, education level, time since diagnosis, disease progression time, current symptoms, presence of comorbities, and medication used for the treatment of PD, classified as dopamine, dopamine plus another anti-Parkinson drug and an anti-Parkinson drug only. 2) the Hoenh and Yahr(14) Scale, which measures the severity of the disease according to the signs and symptoms presented. The researcher applies this scale from the observation of the eight stage clinical picture: 0 (zero) for no sign of the disease; 1 for unilateral disease only; 1.5 for unilateral and axial impairment; 2 for bilateral disease, without impairment of equilibrium; 2.5 for bilateral disease with mild impairment of equilibrium; 3 for bilateral disease with mild and moderate impairment of equilibrium; 4 for severe disability, though capable of standing and walking without help and 5 for individuals in a wheelchair or confined to bed, in need of full help. For this study, the stages were grouped into three levels of impairment, defined as mild (0–2.0), moderate (2.5– 3.0) and severe (3.0–4.0)(15). 3) PDQ-39 (Parkinson’s Disease Quality of Life Questionnaire) which is a specific questionnaire to measure the perception of quality of life of individuals with PD(16). It contains 39 questions divided into eight dimensions: mobility, activities of daily living, emotions, stigma, social support, cognition, communication and bodily discomfort. The questions refer to the frequency in which individuals have encountered difficult situations during the previous month, which is graded, by the interviewee, with scores from 0 (never) to 4 (always). The overall score value or that of each dimension was obtained by using the following calculation:

Parkinson´s disease is of key importance as new biopsychosocial models of medicine are adopted(9). The majority of PD studies focus on physical impairment and medication effects, aiming to obtain subsidies to improve the planning of therapeutic interventions directed toward these individuals(7,10), considering that the aim of therapy in patients with incurable chronic disorders, such as Parkinson´s disease, is to improve their quality of life However, include
(11)

. anxiety, impairment

neuropsychiatric

depression,

and psychosis are very common(12).

All these factors

influence the quality of life of the PD patient, so that they have an individual perception of their real chronic health condition and how it impacts on their quality of life(13). Therefore, the length time living with the disease may or may not predict the degree of impairment in the quality of life of the PD patient. It is important to identify those factors that most influence the quality of life of the PD patient, considering that these issues may not be evident upon clinical examination, not being part of the more common motor symptoms(9). Therefore, investigating the quality of life becomes crucial in order to understand the course of the disease and to seek strategies to promote the physical and psychic well-being of these individuals, thus improving the planning of therapeutic intervention directed toward them. Understanding these factors contributes to the knowledge and increases the commitment to quality of life which can better target the practice of nursing and of other professionals who work directly with patients and their families. Considering the above, this study aimed to evaluate the quality of life of individuals with PD and to identify whether a relationship exists between time of evolution and the disease severity.

Method
Data were collected from March to June of 2008, in the city of Maringá – Paraná – Brazil, with Parkinson patients enrolled at the Parkinson’s Association of Maringá (PAM). This association is a civil, non-profit institution, created in 2004, the aim of which is to bring together and offer support to PD patients and their families. Monthly talks are given by Health

sum of scores of each question within the dimension 4 (maximum score per question) X nº of questions within the dimension

X 100

www.eerp.usp.br/rlae

Navarro-Peternella FM, Marcon SS. The score is a value from 0 to 100%, with the higher final score equating to the individual having a lower perception of his/her quality of life(5). Data were organized in an Excel 2003 spreadsheet and analyzed using SPSS (Statistical Package for the Social Sciences), version 13.0 for Windows. According to the Kolmogorov-Smirnov test, all the variables presented normal distribution, except for the Hohen and Yahr Scale and the social support dimension of the PDQ39. For the evaluation of the hypothesis of difference among groups, the Student’s t test was used for the normally distributed variables, in order to compare the two independent groups and the ANOVA, following Bonferroni’s ad hoc test for multiple comparisons. However, for the variables that did not present normal distribution, the Mann-Whitney test was used in order to compare two independent groups, using p

Similar Documents

Premium Essay

Parkinson's Research Paper

...WHAT IS PARKINSON’S? Neurologists say that Parkinson’s is a variable disease. Persons with Parkinson’s get the disease at different ages and have symptoms that can progress at different degrees. TREATMENT Dopamine replace therapy is one of the treatments for Parkinson’s. Dopamine sends signals to other nerve cells in brain and has a stimulant effect on central nervous system. The treatment response is different to each patient. Some are too sensitive to the medication, some are much less sensitive. SIDE EFFECTS OF TREATMENT The side effects vary from dyskinesias (a movement disorder) to hallucinations. WHAT ARE THE SYMPTOMS? Neurologists say that the symptoms of Parkinson’s varies a lot. Persons get the disease at different ages and have...

Words: 784 - Pages: 4

Premium Essay

Disorder Paper

...Disorder Paper LaTridia M. Chambers Psych/575 November 15, 2012 Dr. Fred Benner Disorder Paper One of the mostly commonly know neurological disorders within society today is Parkinson’s disease. It is classified as a neurodegenerative disorder (Healthwise, 2010). As of today there isn’t a known cure for Parkinson’s disease. Most patients are diagnosed after age of 60, but symptoms can begin much sooner. The most well-known case of this happening is the case of celebrity Michael J. Fox that was diagnosed at the age of 30 with Parkinson’s disease (MedicineNet, 2004). In order to understand treatment methods, it is essential to understand the history, causes, symptoms and pathology of Parkinson’s disease. The disease received its name from James Parkinson, an English doctor (Jankovic, 2008). Parkinson wrote a paper in 1817 entitled “An Essay on the Shaking Palsy.” In the essay, Parkinson reviewed the cases of 6 of his patients who exhibited symptoms of what is now known as Parkinson’s disease. The disease is complicated to explain. It is caused by a defect in nerve cells in the brain. In normal brains, nerve cells make dopamine. Dopamine in turn is the chemical that tells parts of the brain to send signals that control movement. The disease takes place because there is a deficiency of dopamine because of a defect with the nerve cells that create the chemical (Freed, 2001). Dopamine in a healthy brain travels between two areas of the brain: The Substantia Nigra...

Words: 3382 - Pages: 14

Premium Essay

Parkinson's Disease: Paralysis Agitans

...Parkinson’s Disease Description Parkinson’s Disease, also known as paralysis agitans, is a chronic and progressive neurological disorder that affects a person’s movement and their ability to function. What that means is that Parkinson’s is long-lasting disease with no cure that will slowly get worse over time. It affects vital cells in a movement control center located in the brain stem called substantia nigra. These cells, or neurotransmitters, are responsible for producing dopamine which regulates movement and emotions. In a person diagnosed with Parkinson’s disease, these neurotransmitters are either malfunctioning or dying off, thus creating a decrease in the amount of dopamine produced. Etiology (Cause) Scientists are currently at a...

Words: 1156 - Pages: 5

Free Essay

Parkinson's Disease

...Parkinson’s Disease Part 1 Melissa Whisman King University NURS 3005 Pathophysiology Jessica Belnap Parkinson’s Disease Part 1 Parkinson’s disease (PD) is a common and complex neurodegenerative disorder. It is second only to Alzheimer’s disease in commonality (Lees, A. J.,2011). Parkinson’s disease is a slowly progressive degenerative disorder and is usually idiopathic. The first extensive description of Parkinson’s Disease was written over 2 hundred years ago. In 1817, English physician James Parkinson write an essay describing six causes of a condition called paralysis agitans (Lees, A.J., 2011). The essay, titled “Essay on the Shaking Palsy” described characteristic traits such as resting tremor, abnormal posture and gait, paralysis, and decreased muscle strength, and the way the condition progressed over a period of time (Lees, A.J., 2011). Early neurologists such as Trousseau, Gowers, Kinnier Wilson, and Erb made contributions to the knowledge of Parkinson’s disease. But the most noteworthy was Jean-Martin Charcot. His specific studies between 1868 and 1881 proved to be the turning point in gaining knowledge about the disease (Lees, A.J., 2011). During this particular period of time, Charcot was able to distinguish between muscle rigidity, muscle weakness, and the slowness of movement, also known as bradykinesia. Charcot was instrumental in renaming the disease in honor of James Parkinson. In 1912, Frederic Lewy observed microscopic particles in the...

Words: 2250 - Pages: 9

Premium Essay

Parkinsons Disease

...Parkinson’s disease is a slowly progressive neurological disorder that’s cause by a depletion of dopamine in the caudate nucleus, putamen, and pallidum, structures in the neostriatum that normally contains high levels of the neurotransmitter dopamine. It was first discovered by a Doctor James Parkinson in 1817. The disease was first known as the “shaking palsy” before being named after James Parkinson. (Ramirez, 2004). One million people are affected by Parkinson's disease in the United States. Worldwide five million people are affected. Parkinson’s disease is an idiopathic disease that occurs in people over 60 years of age. However study also shows that a small number of people 40 years of age also have Parkinsons. It affects both men and women. It is rare in children. Having a close relative with Parkinson's increases the chances that a person can also develop the disease. Exposure to herbicides and pesticides increases the risk for Parkinson's. Symptoms for Parkinson’s disease are easily noticeable. They may be mild at first. For instance, you may have a mild tremor or a slight feeling that one leg or foot is stiff and dragging. The characteristic shaking associated with Parkinson's disease often begins in a hand. A back-and-forth rubbing of your thumb and forefinger, known as pill-rolling, is common, and may occur when your hand is at rest. However, not everyone experiences tremors. Bradykinesia or slowed movements occur. Parkinsons decreases the ability to...

Words: 1641 - Pages: 7

Premium Essay

Parkinson's Disease Thesis

...Ask the expert Parkinson’s disease Parkinson’s disease is a chronic and degenerative neurological disease that occurs in 1 in 100 hundred people that are over 60 years old. But there are also people that are diagnosed with this disease as young as 18 years old. This disease develops gradually and in the beginning you may not even feel anything wrong with your body. But as time goes by, the symptoms will show up on your body and progressively worsens. Parkinson’s disease is caused by a deterioration of neurons in an area of brain known as the substantia nigra. This substantia nigra cells produce dopamine, a chemical messenger allowing communication between substantia nigra and other parts of the brain. The communication between these cells...

Words: 1029 - Pages: 5

Premium Essay

Unit 14 P1

...investigations that are carried out to enable the diagnosis of these physiological disorders. M1, Asses possible difficulties involved in the diagnosis of the disorders from the signs and symptoms. P1, Parkinson’s disease Nature of disaster Causes, Parkinson’s disease is caused by a loss of nerve cells in the part of our brain and this is called substantia nigra. Also the nerve cells in our brain are responsible for producing a chemical and that is called the dopamine. However the dopamine acts like a messenger between the parts of the brain and then the nervous system that helps to control and to co-ordinate body movements. If our nerve cells gets damaged then the dopamine in our brain is reduced, and this shows that the part of our brain controlling movement will not work as before. It will cause the movements and abnormal to become slow. It is not known why the loss of nerve cells associated with Parkinson's disease occurs, currently; it is...

Words: 2648 - Pages: 11

Premium Essay

Parkinson Disease Research Paper

...care with individuals that is diagnosed with Parkinson disease . Effective patient-centered care is for individuals with Parkinson Disease which requires participation from the family and health care providers for a successful care. Parkinson disease is a progressive neurodegenerative infection that affects an individual's motor system. Parkinson disease progresses in three stages: early, moderate, and advanced. As the disease progresses, the complexity of motor and non motor skills increases. Due to the progression of the degenerative symptoms, patients with Parkinson disease are dependent on others for care as...

Words: 953 - Pages: 4

Premium Essay

Parkinson's Disease

...Parkinson’s Disease Carley Drye Bio 330-002 Dr. Blais Parkinson’s disease (PD) is a neurodegenerative disease that falls under the category of motor disorders. It is caused by the loss of dopamine-producing neurons, which allow for the ability to move with ease. The four signature symptoms of PD are a resting tremor, stiffness, slowness of movement, and postural instability. The disease is most common in people over the age of fifty and also affects more men than women. 6,000 people in the United States are diagnosed each year with the disease. There are currently no consistent blood or imaging tests that indicate a person has Parkinson’s. Instead, a complete family history is taken, and a neurological examination is performed by the physician to test for the most common symptoms. There is presently no cure for this progressive disease, but several treatments have been developed that effectively treat many of the symptoms. The discovery of Parkinson’s disease began in 1817 when James Parkinson wrote a book after observing several patients in his hospital with what he called a “shaking palsy” (1). Fifty years later, in 1867, the scientist Jean-Martin Charcot broadened the description of the disease. He and his students were able to distinguish PD from multiple sclerosis and other diseases characterized by tremoring. Additionally, they developed a clinical spectrum for the disease based on different typed of symptoms (1). They had observed that...

Words: 2971 - Pages: 12

Premium Essay

Essay On Parkinson's Disease

...Abstract Research has shown that a high number of individuals with Parkinson’s disease also present with speech and voice disorder. While this occurs in the majority of individuals, a small minority receive speech and language treatment. This needs analysis aims to investigate the current status and potential barriers in delivery of speech and language treatment to individuals with Parkinson’s disease, and explore how this need can be addressed through introduction of e-health. In this instance, the e-health application LSVT companion has been researched and proposed as an e-health solution. A number of studies were analysed to support this application, as well as acknowledgement of position statements, legislation, policy and recommendations from key stakeholders. Findings indicate that while there are a number of current barriers that hinder treatment of any kind, future implementation of the LSVT companion in Australia will ensure that speech pathology services are available to all individuals with Parkinson’s disease. Introduction Parkinson’s disease (PD) is a progressive neurologic condition, which is currently estimated to affect up to 80, 000 Australians. Current statistics indicate that one person with PD is diagnosed...

Words: 931 - Pages: 4

Free Essay

Personal Impact Paper

...known that people suffering from chronic diseases have major impact in the healthcare delivery systems, including the elderly population over the age of 65. With the advances in technology combined with the aging population, more people are living longer with chronic diseases. Longer life expectancies count for higher costs in healthcare for the treatment, management and prevention of further complications arising from chronic diseases. The third most common chronic disease of the older adults is Parkinson’s disease. It is a debilitating disease affecting a person’s motor ability, causing tremors, rigidity, akinesia or slow movement, and postural instability. According to the National Institutes of Health, about 500, 000 individuals in the United States suffer from Parkinson’s Disease, and it is estimated that males are more often affected than females. Parkinson’s disease has a large economic impact and directly affects medical costs, as well as the affecting the person financially, such as lost wages and decreased productivity. According to a recent interview with a client suffering from PD over the course of ten years, the disability directly impacted his personal life, financial status, and family members. The next discussion talks about how the patient learned about his disease and the personal impact it created at the beginning of the disease process until the peak onset later in his life. How the patient learned about his disease During the interview with the 65 year...

Words: 1591 - Pages: 7

Free Essay

Diabetes

...living with Parkinson’s disease Welcome to the second edition of the ‘Guide to living with Parkinson’s disease’, produced by H Lundbeck A/S and Teva Pharmaceutical Industries in close collaboration with the European Parkinson’s Disease Association (EPDA). This guide has been designed to answer the most immediate questions of a person diagnosed with Parkinson’s disease and their carer. It provides information on the disease itself, as well as the many aspects of treatment and practical disease management, including medications, surgery, diet, exercise/physiotherapy, and emotional support. Another very important part of living with Parkinson’s disease is keeping a full and active life while maintaining good communication with others. With this in mind, the guide contains hints, tips and tools to help in daily communication with carers, family, friends and children, as well as with doctors and other members of the healthcare team. These resources can be used every day alongside the other elements of the binder, such as the ‘Guide to healthy eating’, the daily diary, and the medication record. In order to keep this booklet a handy size, it has not been possible to include advice on every aspect of life with Parkinson’s disease. However, where a subject is not dealt with in detail, the reader is directed towards other sources (books, websites, etc.) where more comprehensive information can be found. We hope that you will find this guide valuable in everyday life, and that the...

Words: 23095 - Pages: 93

Premium Essay

Lewy Body Dementia Research Paper

...diagnosis to a specific type of Dementia. Alzheimer’s disease is one of the most common forms. Alzheimer’s disease is irreversible, progressive and it destroys memory, and cognitive skills. The specific type that will be discussed is Lewy Body Dementia. “Lewy Body Dementia is associated with abnormal deposits of a protein called alpha-synuclein in the brain. These deposits, called Lewy bodies, affect chemicals in the brain whose changes, in turn, can lead to problems with thinking, movement, behavior...

Words: 900 - Pages: 4

Premium Essay

Dementia Care

...abilities. This includes problems with: * memory loss * thinking speed * mental agility * language * understanding * judgment People with dementia can lose interest in their usual activities, and have problems controlling their emotions. They may also find social situations challenging, lose interest in socializing, and aspects of their personality may change. A person with dementia may lose empathy (understanding and compassion), they may see or hear things that other people do not (hallucinations), or they may make false claims or statements. As dementia affects a person's mental abilities, they may find planning and organizing difficult. Being independent may also become a problem. A person with dementia will therefore usually need help from friends or relatives, including help with decision making. Most types of dementia can't be cured, but if it is detected early there are ways to slow it down and maintain mental function. Dementia is a collection of symptoms including memory loss, personality change, and impaired intellectual functions resulting from disease or trauma to the brain. These changes are not part of normal aging and are severe enough to impact daily living, independence, and relationships. There will likely be noticeable decline in communication, learning, remembering, and problem solving. These changes may occur quickly or very slowly over time. Common signs and symptoms of dementia include: * Memory loss * Impaired judgment...

Words: 1888 - Pages: 8

Premium Essay

L-Copa Research Paper

...Parkinson’s disease is associated with a lack of dopamine in the brain. It affects thousands of people, generally the older population, causing tremors and muscle rigidity (Yahr). Currently, there is no cure and people turn to medication, deep brain stimulation, or fetal brain implants. Every patient is different and reacts differently to the array of treatments. The problem with dopamine is that it cannot simply be injected into the person to serve as a cure because it cannot cross the blood brain barrier. Fortunately, scientists discovered L-DOPA, which is a precursor to dopamine and can cross the blood brain barrier. However, L-DOPA cannot be used for the long term because eventually the person develops a tolerance. Once a tolerance develops, the cons start to outweigh the benefits and the treatment stops. Deep brain stimulation is something scientists do not fully understand, but has proved successful in suppressing symptoms. This treatment uses a pacemaker-like device that is connected to an electrode implanted in the brain (Yahr). I support deep brain stimulation because it is a great...

Words: 872 - Pages: 4